Rheumatology NewsCompounding rules challenge practice normsApril 10, 2017OsteoarthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitisRheumatoid ArthritisSpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsSecukinumab beat etanercept in 52-week psoriasis quality of life analysisApril 9, 2017Psoriatic Arthritis
Rheumatology NewsIxekizumab found superior to ustekinumab in psoriasis at 24 weeksMarch 22, 2017Psoriatic Arthritis
Rheumatology NewsShingles vaccine deemed effective in people with autoimmune diseaseMarch 21, 2017Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Rheumatology NewsAdalimumab for psoriasis: Blocking TNF-alpha had no effect on vascular inflammationMarch 15, 2017Psoriatic Arthritis
Rheumatology NewsCDC: Greater activity limitations accompany rising arthritis prevalenceMarch 7, 2017OsteoarthritisRheumatoid ArthritisLupus & Connective Tissue DiseasesGoutPsoriatic Arthritis
Rheumatology NewsBiosimilars: No big dollar savings, but are clinically ‘dead on’March 7, 2017Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisBusiness of Medicine
Rheumatology NewsCIMPASI-1 and -2 show certolizumab pegol benefits patients with severe plaque psoriasisMarch 5, 2017Psoriatic Arthritis
Rheumatology NewsHumira Pen topped per-person drug spending in 2016February 28, 2017Rheumatoid ArthritisPsoriatic ArthritisBusiness of Medicine
Rheumatology NewsBrodalumab approved for psoriasis with REMS requiredFebruary 16, 2017Psoriatic Arthritis
